In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Vilekar, Prachi ^a   Awasthi, Vibhudutta ^a   Lagisetty, Pallavi ^a   King, Catherine ^a   Shankar, Nathan ^a   Awasthi, Shanjana ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; COMPLEMENTARY DNA; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLASMID DNA; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; DRUG DERIVATIVE; EPITOPE; FIALURIDINE; FUNGUS VACCINE; URACIL ARABINOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL HOMING; CELL STRUCTURE; COCCIDIOIDES; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNOSTIMULATION; IN VIVO STUDY; LUNG; MEMORY T LYMPHOCYTE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PHENOTYPE; T LYMPHOCYTE ACTIVATION; THYMUS; TRANSGENE; UPREGULATION; VACCINATION; ANIMAL; ANIMAL MODEL; CELL CULTURE; CELL SHAPE; CYTOLOGY; DENDRITIC CELL; GENETICS; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; INTRANASAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; PLASMID; SECRETION; TISSUE DISTRIBUTION;

ADMINISTRATION, INTRANASAL; ANIMALS; ARABINOFURANOSYLURACIL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SHAPE; CELLS, CULTURED; COCCIDIOIDES; CYTOKINES; DENDRITIC CELLS; DNA, COMPLEMENTARY; EPITOPES; FUNGAL VACCINES; IMMUNIZATION; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MICE; MODELS, ANIMAL; MOLECULAR IMAGING; PLASMIDS; THYMIDINE KINASE; TISSUE DISTRIBUTION; TRANSFECTION; TRANSGENES;

EID: 78650993712     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-60     Document Type: Article

References (51)

1. Laniado-Laborin R. Expanding understanding of epidemiology of coccidioidomycosis in the Western hemisphere. Ann N Y Acad Sci 2007, 1111:19-34. 10.1196/annals.1406.004, 17395731.
2. Adam RD, Elliott SP, Taljanovic MS. The spectrum and presentation of disseminated coccidioidomycosis. Am J Med 2009, 122:770-7. 10.1016/j.amjmed.2008.12.024, 19635278.
3. Increase in Coccidioidomycosis - California, 2000-2007. MMWR Morb Mortal Wkly Rep 2009, 58:105-9.
4. Warnock DW. Coccidioides species as potential agents of bioterrorism. Future Microbiol 2007, 2:277-83. 10.2217/17460913.2.3.277, 17661702.
5. Cox RA, Magee DM. Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev 2004, 17:804-39. table of contents, 10.1128/CMR.17.4.804-839.2004, 523560, 15489350.
6. Richards JO, Ampel NM, Galgiani JN, Lake DF. Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation. J Infect Dis 2001, 184:1220-4. 10.1086/323664, 11598850.
7. Richards JO, Ampel NM, Lake DF. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis. J Immunol 2002, 169:2020-5.
8. Awasthi S, Magee DM. Differences in expression of cell surface co-stimulatory molecules, Toll-like receptor genes and secretion of IL-12 by bone marrow-derived dendritic cells from susceptible and resistant mouse strains in response to Coccidioides posadasii. Cell Immunol 2004, 231:49-55. 10.1016/j.cellimm.2004.11.006, 15919369.
9. del Pilar Jimenez AM, Viriyakosol S, Walls L, Datta SK, Kirkland T, Heinsbroek SE, Brown G, Fierer J. Susceptibility to Coccidioides species in C57BL/6 mice is associated with expression of a truncated splice variant of Dectin-1 (Clec7a). Genes Immun 2008, 9:338-48. 10.1038/gene.2008.23, 18418396.
10. Rinaldo CR. Dendritic cell-based human immunodeficiency virus vaccine. J Intern Med 2009, 265:138-58. 10.1111/j.1365-2796.2008.02047.x, 2875880, 19093966.
11. Whiteside TL, Piazza P, Reiter A, Stanson J, Connolly NC, Rinaldo CR, Riddler SA. Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 2009, 16:233-40. 10.1128/CVI.00066-08, 2643533, 19038780.
12. Engell-Noerregaard L, Hansen TH, Andersen MH, Thor Straten P, Svane IM. Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Cancer Immunol Immunother 2009, 58:1-14. 10.1007/s00262-008-0568-4, 18719915.
13. Tan YF, Sim GC, Habsah A, Leong CF, Cheong SK. Experimental production of clinical-grade dendritic cell vaccine for acute myeloid leukemia. Malays J Pathol 2008, 30:73-9.
14. Burgdorf SK, Fischer A, Myschetzky PS, Munksgaard SB, Zocca MB, Claesson MH, Rosenberg J. Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine. Oncol Rep 2008, 20:1305-11.
15. Zhou Q, Guo AL, Xu CR, An SJ, Wang Z, Yang SQ, Wu YL. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro. Clin Exp Immunol 2008, 153:392-400. 10.1111/j.1365-2249.2008.03724.x, 2527369, 18803763.
16. Walker DG, Laherty R, Tomlinson FH, Chuah T, Schmidt C. Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy. J Clin Neurosci 2008, 15:114-21. 10.1016/j.jocn.2007.08.007, 18083572.
17. Murthy V, Moiyadi A, Sawant R, Sarin R. Clinical considerations in developing dendritic cell vaccine based immunotherapy protocols in cancer. Curr Mol Med 2009, 9:725-31. 10.2174/156652409788970689, 19689299.
18. Gilboa E. DC-based cancer vaccines. J Clin Invest 2007, 117:1195-203. 10.1172/JCI31205, 1857263, 17476349.
19. Wheeler CJ, Black KL. DCVax-Brain and DC vaccines in the treatment of GBM. Expert Opin Investig Drugs 2009, 18:509-19. 10.1517/13543780902841951, 19335279.
20. Antonarakis ES, Drake CG. Current status of immunological therapies for prostate cancer. Curr Opin Urol 2010, 20:241-6. 10.1097/MOU.0b013e3283381793, 20179598.
21. Patel PH, Kockler DR. Sipuleucel-T: a vaccine for metastatic, asymptomatic, androgen-independent prostate cancer. Ann Pharmacother 2008, 42:91-8.
22. Awasthi S, Cox RA. Transfection of murine dendritic cell line (JAWS II) by a nonviral transfection reagent. Biotechniques 2003, 35. 600-2, 4.
23. Awasthi S, Awasthi V, Magee DM, Coalson JJ. Efficacy of Antigen 2/Proline-Rich Antigen cDNA-Transfected Dendritic Cells in Immunization of Mice against Coccidioides posadasii. J Immunol 2005, 175:3900-6.
24. Awasthi S. Dendritic cell-based vaccine against coccidioides infection. Ann N Y Acad Sci 2007, 1111:269-74. 10.1196/annals.1406.013, 17363430.
25. Holmstrom K, Pedersen AW, Claesson MH, Zocca MB, Jensen SS. Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy. Hum Immunol 2009, 71:67-73.
26. van Kooten C, Stax AS, Woltman AM, Gelderman KA. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs. Handb Exp Pharmacol 2009, 233-49. full_text, 19031029.
27. Dohnal AM, Graffi S, Witt V, Eichstill C, Wagner D, Ul-Haq S, Wimmer D, Felzmann T. Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines. J Cell Mol Med 2009, 13:125-35. 10.1111/j.1582-4934.2008.00304.x, 18363835.
28. Lesterhuis WJ, Aarntzen EH, De Vries IJ, Schuurhuis DH, Figdor CG, Adema GJ, Punt CJ. Dendritic cell vaccines in melanoma: from promise to proof?. Crit Rev Oncol Hematol 2008, 66:118-34. 10.1016/j.critrevonc.2007.12.007, 18262431.
29. Jiang X, Shen C, Rey-Ladino J, Yu H, Brunham RC. Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity. Infect Immun 2008, 76:2392-401. 10.1128/IAI.01584-07, 2423070, 18362126.
30. Awasthi S, Cropper J. Immunophenotype and functions of fetal baboon bone-marrow derived dendritic cells. Cell Immunol 2006, 240:31-40. 10.1016/j.cellimm.2006.06.001, 16842767.
31. Daugelat S, Ladel CH, Kaufmann SH. Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guerin. Infect Immun 1995, 63:2033-40. 173261, 7537253.
32. Gemmell E, Winning TA, Grieco DA, Bird PS, Seymour GJ. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice. J Periodontol 2000, 71:1130-8. 10.1902/jop.2000.71.7.1130, 10960020.
33. Gemmell E, Sernia C, Grieco DA, Bird PS, Allen CJ, Seymour GJ. Genetic variation in the recognition of Porphyromonas gingivalis antigens in mice. Oral Microbiol Immunol 2001, 16:129-35. 10.1034/j.1399-302x.2001.016003129.x, 11358534.
34. Baumjohann D, Lutz MB. Non-invasive imaging of dendritic cell migration in vivo. Immunobiology 2006, 211:587-97. 10.1016/j.imbio.2006.05.011, 16920497.
35. Celli S, Breart B, Bousso P. Intravital two-photon imaging of natural killer cells and dendritic cells in lymph nodes. Methods Mol Biol 2008, 415:119-26. full_text, 18370151.
36. Celli S, Garcia Z, Beuneu H, Bousso P. Decoding the dynamics of T cell-dendritic cell interactions in vivo. Immunol Rev 2008, 221:182-7. 10.1111/j.1600-065X.2008.00588.x, 18275482.
37. Pham W, Kobukai S, Hotta C, Gore JC. Dendritic cells: therapy and imaging. Expert Opin Biol Ther 2009, 9:539-64. 10.1517/14712590902867739, 19392575.
38. Narsinh KH, Cao F, Wu JC. Molecular imaging of human embryonic stem cells. Methods Mol Biol 2009, 515:13-32. full_text, 19405224.
39. Waerzeggers Y, Klein M, Miletic H, Himmelreich U, Li H, Monfared P, Herrlinger U, Hoehn M, Coenen HH, Weller M, Winkeler A, Jacobs AH. Multimodal imaging of neural progenitor cell fate in rodents. Mol Imaging 2008, 7:77-91.
40. Miyagawa T, Gogiberidze G, Serganova I, Cai S, Balatoni JA, Thaler HT, Ageyeva L, Pillarsetty N, Finn RD, Blasberg RG. Imaging of HSV-tk Reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. J Nucl Med 2008, 49:637-48. 10.2967/jnumed.107.046227, 18344433.
41. Doubrovin MM, Doubrovina ES, Zanzonico P, Sadelain M, Larson SM, O'Reilly RJ. In vivo imaging and quantitation of adoptively transferred human antigen-specific T cells transduced to express a human norepinephrine transporter gene. Cancer Res 2007, 67:11959-69. 10.1158/0008-5472.CAN-07-1250, 18089827.
42. Kang TH, Lee JH, Noh KH, Han HD, Shin BC, Choi EY, Peng S, Hung CF, Wu TC, Kim TW. Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments. Int J Cancer 2007, 120:1696-703. 10.1002/ijc.22377, 17230516.
43. Peng S, Kim TW, Lee JH, Yang M, He L, Hung CF, Wu TC. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum Gene Ther 2005, 16:584-93. 10.1089/hum.2005.16.584, 15916483.
44. Chen M, Huang L, Shabier Z, Wang J. Regulation of the lifespan in dendritic cell subsets. Mol Immunol 2007, 44:2558-65. 10.1016/j.molimm.2006.12.020, 2851400, 17267035.
45. Ahlers JD, Belyakov IM. Memories that last forever: strategies for optimizing vaccine T cell memory. Blood 2009, 115:1678-89. 10.1182/blood-2009-06-227546, 2920202, 19903895.
46. Wakim LM, Waithman J, van Rooijen N, Heath WR, Carbone FR. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008, 319:198-202. 10.1126/science.1151869, 18187654.
47. Ampel NM, Nelson DK, Chavez S, Naus KA, Herman AB, Li L, Simmons KA, Pappagianis D. Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis. Clin Diagn Lab Immunol 2005, 12:700-4. 1151974, 15939743.
48. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999, 223:77-92. 10.1016/S0022-1759(98)00204-X, 10037236.
49. Yaghoubi SS, Gambhir SS. Measuring herpes simplex virus thymidine kinase reporter gene expression in vitro. Nat Protoc 2006, 1:2137-42. 10.1038/nprot.2006.334, 17487205.
50. Kang KW, Min JJ, Chen X, Gambhir SS. Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture. Mol Imaging Biol 2005, 7:296-303. 10.1007/s11307-005-0010-7, 16041591.
51. Choi SR, Zhuang ZP, Chacko AM, Acton PD, Tjuvajev-Gelovani J, Doubrovin M, Chu DC, Kung HF. SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [(123)I]FIAU(1). Acad Radiol 2005, 12:798-805. 10.1016/j.acra.2005.04.010, 16039533.